Marco Soriani | Project Director
ReiThera Srl

Marco Soriani, Project Director, ReiThera Srl

Marco Soriani, is a cellular microbiologist with more than 25 years in the field of infectious disease and vaccines. Currently, he acts as Project Director at Reithera (Rome, Italy), where he leads the Project Management Office. Regarding his scientific background, after qualifying in Biology at La Sapienza University in Rome, he studied for a doctoral degree in Biochemistry at the University of Zurich. In 1996, he began a post-doctoral tenure at the Swiss Institute for Experimental Cancer Research, Epalinges (Switzerland) and then moved to UK as a researcher at the University of Bristol (UK). In 2002, he joined Rino Rappuoli’s team at the Vaccine Research Centre in Siena. During this period, he has built a prestigious career in the vaccine field, reaching important achievements from the discovery on novel vaccine candidates to the direction of scientific programs. Marco Soriani is author of more than sixty scientific papers in high-ranking international journals and he has been in the board of several EU projects, also acting as Vice Chair for the European Research Executive Agency.

Appearances:



Day 2 - Wednesday 15th October @ 12:10

The journey of the Gorilla Adenoviral Platform: from COVID to HIV

Session led by: ReiThera Srl

Day 2 - Wednesday 15th October @ 12:10

The journey of the Gorilla Adenoviral Platform: from COVID to HIV

Session led by: ReiThera Srl
last published: 12/Sep/25 15:05 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.